Research Grade Anti-Human CD19 Antibody (Immunomedics hA19)Anti-Human CD19 Antibody (Immunomedics hA19) ( HB996336 ) is a research-grade recombinant antibody targeting CD19 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4 | | Accession | P15391 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-658-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-Human CD19 Antibody (Immunomedics hA19).
Примечание: |
|
